Anil R. Diwan Ph.D.
Net Worth

Last updated:

What is Anil R. Diwan Ph.D. net worth?

The estimated net worth of Dr. Anil R. Diwan Ph.D. is at least $8,692,157 as of 22 Sep 2015. He owns shares worth $3,021,045 as insider, has earned $71,112 from insider trading and has received compensation worth at least $5,600,000 in NanoViricides, Inc..

What is the salary of Anil R. Diwan Ph.D.?

Dr. Anil R. Diwan Ph.D. salary is $400,000 per year as Executive Chairman, Pres, Chief Executive Officer & Sec. in NanoViricides, Inc..

How old is Anil R. Diwan Ph.D.?

Dr. Anil R. Diwan Ph.D. is 66 years old, born in 1959.

What stocks does Anil R. Diwan Ph.D. currently own?

As insider, Dr. Anil R. Diwan Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
NanoViricides, Inc. (NNVC) Executive Chairman, Pres, Chief Executive Officer & Sec. 2,069,918 $1.46 $3,021,045

What does NanoViricides, Inc. do?

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

NNVC logo
NNVC
NanoViricides, Inc.
$1.46

Anil R. Diwan Ph.D. insider trading

NanoViricides, Inc.

Dr. Anil R. Diwan Ph.D. has made 79 insider trades between 2011-2015, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 285,715 units of NNVC stock on 22 Sep 2015. As of 22 Sep 2015 he still owns at least 2,069,918 units of NNVC stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock Options 285,715 N/A N/A
Option
Common Stock, par value $0.001 per share 208,771 N/A N/A
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 23,392 $2.61 $61,053
Purchase
Common Stock 23,392 N/A N/A
Purchase
Common Stock 4,000 N/A N/A
Purchase
Common Stock, par value $0.001 per share 28,571 N/A N/A
Purchase
Common Stock 15,000 N/A N/A
Purchase
Common Stock 35,000 N/A N/A
Sale
Common Stock 142,000 N/A N/A
Purchase
Common Stock 147,000 N/A N/A
Sale
Common Stock 147,000 N/A N/A
Sale
Common Stock 100,000 N/A N/A
Purchase
Common Stock 100,000 N/A N/A
Purchase
Common Stock 250,000 N/A N/A
Sale
Common Stock 250,000 N/A N/A
Sale
Common Stock 39,375 N/A N/A
Sale
Common Stock 18,000 N/A N/A
Sale
Common Stock 26,000 N/A N/A
Sale
Common Stock 12,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 17,000 N/A N/A
Sale
Common Stock 11,000 N/A N/A
Sale
Common Stock 25,000 N/A N/A
Sale
Common Stock 35,000 N/A N/A
Sale
Common Stock 9,930 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 26,600 N/A N/A
Sale
Common Stock 20,500 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 7,500 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 46,000 N/A N/A
Sale
Common Stock 60,160 $0.54 $32,186
Sale
Common Stock 60,160 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 11,850 N/A N/A
Sale
Common Stock 12,625 N/A N/A
Sale
Common Stock 23,900 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 16,400 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 14,500 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 9,200 N/A N/A
Sale
Common Stock 18,375 N/A N/A
Sale
Common Stock 27,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 16,000 N/A N/A
Sale
Common Stock 24,600 N/A N/A
Sale
Common Stock 44,000 N/A N/A
Sale
Common Stock 60,000 N/A N/A
Sale
Common Stock 22,500 N/A N/A
Sale
Common Stock 21,900 N/A N/A
Sale
Common Stock 38,000 N/A N/A
Sale
Common Stock 7,500 N/A N/A
Sale
Common Stock 7,500 N/A N/A
Sale
Common Stock 7,500 N/A N/A
Sale
Common Stock 11,000 $1.23 $13,486
Sale
Common Stock 11,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 11,675 N/A N/A
Sale
Common Stock 7,500 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 7,600 N/A N/A
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 16,000 N/A N/A
Sale
Common Stock 29,500 N/A N/A
Sale
Common Stock 57,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Sale
Common Stock 10,000 $1.21 $12,100
Sale
Common Stock 10,000 N/A N/A
Sale
Common Stock 11,500 $1.16 $13,340
Sale
Common Stock 11,500 N/A N/A
Sale
Common Stock 12,500 N/A N/A
Sale
Common Stock 40,000 N/A N/A
Sale
Common Stock 10,500 N/A N/A
Sale
Common Stock 25,695 N/A N/A
Sale
Common Stock 10,750 N/A N/A
Sale
Common Stock 11,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A

NanoViricides key executives

NanoViricides, Inc. executives and other stock owners filed with the SEC:

  • Dr. Anil R. Diwan Ph.D. (66) Executive Chairman, Pres, Chief Executive Officer & Sec.
  • Ms. Meeta R. Vyas B.S., M.B.A., SB, MBA (66) Chief Financial Officer